The four-year, $2.3 million project could accelerate the development of new therapies for a range of cancers, particularly metastatic breast cancer. It also offers an answer to a longstanding mystery in cancer metabolism.
Recent breakthroughs from Professor Duc Dong and his team bring great promise to the Alagille community and are also cause for the wider rare disease community to pay attention.
San Diego group has provided more than $2 million to early-career scientists across the country conducting maverick research on Type 1 diabetes, including the lab run by developmental geneticist Duc Dong at Sanford Burnham Prebys.